| User's Publication |
|
21684
Masuda Y, Yamashita S, Nakayama Y, Shimizu R, Konishi M.
Maitake Beta-Glucan Enhances the Therapeutic Effect of Trastuzumab via Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity.
Biol Pharm Bull
2024
47(4):840-847
PubMed ID: 38616114
DOI: 10.1248/bpb.b23-00802
|
|
21802
Akimoto T, Islam MR, Nagasako A, Kishi K, Nakakaji R, Ohtake M, Hasumi H, Yamaguchi T, Yamada S, Yamamoto T, Ishikawa Y, Umemura M.
Alternative magnetic field exposure suppresses tumor growth via metabolic reprogramming.
Cancer Sci
2024
PubMed ID: 38877783
DOI: 10.1111/cas.16243
|
|
22025
Hong L, Tanaka M, Yasui M, Hara-Chikuma M.
HSP90 promotes tumor associated macrophage differentiation during triple-negative breast cancer progression.
Sci Rep
2024
14(1):22541
PubMed ID: 39341960
DOI: 10.1038/s41598-024-73394-9
|
|
17582
Sugiura S, Yamahira S, Tamura M, Shin K, Shibuta M, Satoh T, Matsuzawa Y, Fujii G, Yanagawa F, Mutoh M, Yanagisawa M, Kato R, Matsui H.
Automated cell isolation from photodegradable hydrogel based on fluorescence image analysis
Biotechnol Bioeng
2023
Mar 15
PubMed ID: 36919627
DOI: 10.1002/bit.28375
|
|
19264
Muguruma M, Asaoka M, Teraoka S, Miyahara K, Kawate T, Ishikawa T.
β-Tubulin Isoforms Related to Docetaxel Sensitivity in 2D and 3D Cultured TNBC Cell Lines
Anticancer Res
2022
42(10):4735-4742
PubMed ID: 36191981
DOI: 10.21873/anticanres.15978
|
|
13416
Sagara M, Miyamoto S, Itoh S, Soda Y, Tani K.
Development of New Oncolytic Virotherapy Targeting Breast Cancer Using Coxsackievirus B3.
Anticancer Res
2021
PubMed ID: 33419801
DOI: 10.21873/anticanres.14753
|
|
20159
Sakabe T, Wakahara M, Shiota G, Umekita Y.
Role of cytoplasmic localization of maspin in promoting cell invasion in breast cancer with aggressive phenotype.
Sci Rep
2021
11(1):11321
PubMed ID: 34059749
DOI: 10.1038/s41598-021-90887-z
|
|
16735
Okada H, Mimura M, Tomita S, Kurita R.
Affinity Diversification of a Polymer Probe for Pattern-recognition-based Biosensing Using Chemical Additives
Anal Sci
2021
37(5):713-719
PubMed ID: 33518589
DOI: 10.2116/analsci.20SCP23
|
|
11952
Kimura R, Yoshimaru T, Matsushita Y, Matsuo T, Ono M, Park JH, Sasa M, Miyoshi Y, Nakamura Y, Katagiri T.
The GALNT6‑LGALS3BP axis promotes breast cancer cell growth.
Int. J. Oncol.
2020
PubMed ID: 31894262
DOI: 10.3892/ijo.2019.4941
|
|
12064
Teraoka S, Muguruma M, Takano N, Miyahara K, Kawate T, Kaise H, Yamada K, Miyazawa K, Ishikawa T.
Association of BRCA Mutantations and BRCAness Status With Anticancer Drug Sensitivities in Triple-Negative Breast Cancer Cell Lines.
J. Surg. Res.
2020
PubMed ID: 32092597
DOI: 10.1016/j.jss.2019.12.040
|
|
13226
Muguruma M, Teraoka S, Miyahara K, Ueda A, Asaoka M, Okazaki M, Kawate T, Kuroda M, Miyagi Y, Ishikawa T.
Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines.
Biochem Biophys Res Commun
2020
PubMed ID: 32958246
DOI: 10.1016/j.bbrc.2020.08.075
|
|
13770
Kim H, Hoshi M, Iijima M, Kuroda S, Nakamura C.
Development of a universal method for the measurement of binding affinities of antibody drugs towards a living cell based on AFM force spectroscopy
Anal Methods
2020
12(22):2922-2927
PubMed ID: 32930215
DOI: 10.1039/d0ay00788a
|
|
14854
Terasaki A, Kurokawa H, Ito H, Komatsu Y, Matano D, Terasaki M, Bando H, Hara H, Matsui H.
Elevated Production of Mitochondrial Reactive Oxygen Species via Hyperthermia Enhanced Cytotoxic Effect of Doxorubicin in Human Breast Cancer Cell Lines MDA-MB-453 and MCF-7
Int J Mol Sci
2020
21(24):9522
PubMed ID: 33333736
DOI: 10.3390/ijms21249522
|
|
11360
Futami K, Kimoto M, Lim YWS, Hirao I.
Genetic Alphabet Expansion Provides Versatile Specificities and Activities of Unnatural-Base DNA Aptamers Targeting Cancer Cells.
Mol Ther Nucleic Acids
2019
PubMed ID: 30594072
DOI: 10.1016/j.omtn.2018.11.011
|
|
11511
Behan FM, Iorio F, Picco G, Gonçalves E, Beaver CM, Migliardi G, Santos R, Rao Y, Sassi F, Pinnelli M, Ansari R, Harper S, Jackson DA, McRae R, Pooley R, Wilkinson P, van der Meer D, Dow D, Buser-Doepner C, Bertotti A, Trusolino L, Stronach EA, Saez-Rodriguez J, Yusa K, Garnett MJ.
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Nature
2019
PubMed ID: 30971826
DOI: 10.1038/s41586-019-1103-9
|
|
11524
Ueda A, Oikawa K, Fujita K, Ishikawa A, Sato E, Ishikawa T, Kuroda M, Kanekura K.
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer.
Lab. Invest.
2019
PubMed ID: 30996295
DOI: 10.1038/s41374-019-0247-4
|
|
11563
Kawase A, Inoue Y, Nakazaki S, Koizumi E, Iwaki M.
Radixin knockdown improves the accumulation and efficiency of methotrexate in tumor cells.
Oncol. Rep.
2019
PubMed ID: 31115547
DOI: 10.3892/or.2019.7162
|
|
14819
Takayama M, Takatsu H, Hamamoto A, Inoue H, Naito T, Nakayama K, Shin HW.
The cytoplasmic C-terminal region of the ATP11C variant determines its localization at the polarized plasma membrane
J Cell Sci
2019
132(17):jcs231720.
PubMed ID: 31371488
DOI: 10.1242/jcs.231720
|
|
11228
Ichihara H, Okumura M, Tsujimura K, Matsumoto Y.
Theranostics with Hybrid Liposomes in an Orthotopic Graft Model Mice of Breast Cancer.
Anticancer Res.
2018
PubMed ID: 30275183
DOI: 10.21873/anticanres.12900
|
|
4120
Miyagawa Y, Matsushita Y, Suzuki H, Komatsu M, Yoshimaru T, Kimura R, Yanai A, Honda J, Tangoku A, Sasa M, Miyoshi Y, Katagiri T.
Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancer.
Int. J. Oncol.
2018
PubMed ID: 29512727
DOI: 10.3892/ijo.2018.4301
|
|
4288
Khatun A, Shimozawa M, Kito H, Kawaguchi M, Fujimoto M, Ri M, Kajikuri J, Niwa S, Fujii M, Ohya S.
Transcriptional Repression and Protein Degradation of the Ca2+-Activated K+ Channel KCa1.1 by Androgen Receptor Inhibition in Human Breast Cancer Cells.
Front Physiol
2018
PubMed ID: 29713287
DOI: 10.3389/fphys.2018.00312
|
|
4376
Fujimoto M, Kito H, Kajikuri J, Ohya S.
Transcriptional repression of human epidermal growth factor receptor 2 by ClC-3 Cl- /H+ transporter inhibition in human breast cancer cells.
Cancer Sci.
2018
109(9):2781-2791
PubMed ID: 29949674
DOI: 10.1111/cas.13715
|
|
9925
Fujimoto M, Inoue T, Kito H, Niwa S, Suzuki T, Muraki K, Ohya S.
Transcriptional repression of HER2 by ANO1 Cl- channel inhibition in human breast cancer cells with resistance to trastuzumab.
Biochem. Biophys. Res. Commun.
2017
482:188-194
PubMed ID: 27838298
DOI: 10.1016/j.bbrc.2016.11.033
|
|
10445
Yamaguchi H, Ito Y, Miura N, Nagamura Y, Nakabo A, Fukami K, Honda K, Sakai R.
Actinin-1 and actinin-4 play essential but distinct roles in invadopodia formation by carcinoma cells.
Eur. J. Cell Biol.
2017
96:685-694
PubMed ID: 28797528
DOI: 10.1016/j.ejcb.2017.07.005
|
|
5680
Ginting TE, Suryatenggara J, Christian S, Mathew G.
Proinflammatory response induced by Newcastle disease virus in tumor and normal cells.
Oncolytic Virother
2017
6:21-30
PubMed ID: 28293547
DOI: 10.2147/OV.S123292
|
|
14384
Miyasato Y, Shiota T, Ohnishi K, Pan C, Yano H, Horlad H, Yamamoto Y, Yamamoto-Ibusuki M, Iwase H, Takeya M, Komohara Y.
High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer
Cancer Sci
2017
108(8):1693-1700
PubMed ID: 28574667
DOI: 10.1111/cas.13287
|
|
9818
Kanzaki H, Shinohara F, Suzuki M, Wada S, Miyamoto Y, Yamaguchi Y, Katsumata Y, Makihira S, Kawai T, Taubman MA, Nakamura Y.
A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma.
Sci Rep
2016
6:32259
PubMed ID: 27573075
DOI: 10.1038/srep32259
|
|
9880
Poulose AC, Veeranarayanan S, Mohamed MS, Aburto RR, Mitcham T, Bouchard RR, Ajayan PM, Sakamoto Y, Maekawa T, Kumar DS.
Multifunctional Cu2-xTe Nanocubes Mediated Combination Therapy for Multi-Drug Resistant MDA MB 453.
Sci Rep
2016
6:35961
PubMed ID: 27775048
DOI: 10.1038/srep35961
|
|
9992
Khatun A, Fujimoto M, Kito H, Niwa S, Suzuki T, Ohya S.
Down-Regulation of Ca2+-Activated K⁺ Channel KCa1.1 in Human Breast Cancer MDA-MB-453 Cells Treated with Vitamin D Receptor Agonists.
Int J Mol Sci
2016
17:
PubMed ID: 27973439
DOI: 10.3390/ijms17122083
|
|
12644
Minatani N, Waraya M, Yamashita K, Kikuchi M, Ushiku H, Kojo K, Ema A, Nishimiya H, Kosaka Y, Katoh H, Sengoku N, Tanino H, Sidransky D, Watanabe M.
Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer
PLoS One
2016
11(1):e0144862
PubMed ID: 26785325
DOI: 10.1371/journal.pone.0144862
|
|
12882
Kikuchi M, Yamashita K, Waraya M, Minatani N, Ushiku H, Kojo K, Ema A, Kosaka Y, Katoh H, Sengoku N, Enomoto T, Tanino H, Sawanobori M, Watanabe M.
Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer
Oncotarget
2016
7(2):1741-53.
PubMed ID: 26646320
DOI: 10.18632/oncotarget.6480
|
|
7226
Subramanian N, Kanwar JR, Kanwar RK, Krishnakumar S.
Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras.
Nucleic Acid Ther
2015
25:317-22
PubMed ID: 26334953
DOI: 10.1089/nat.2015.0550
|
|
7287
Iida R, Ueki M, Yasuda T.
Identification of interacting partners of Human Mpv17-like protein with a mitigating effect of mitochondrial dysfunction through mtDNA damage.
Free Radic. Biol. Med.
2015
87:336-45
PubMed ID: 26165189
DOI: 10.1016/j.freeradbiomed.2015.07.008
|
|
9408
Yasunori Sato, Naoto Sasaki, Megu Saito, Nao Endo, Fumihiko Kugawa, Akemichi Ueno
Luteolin Attenuates Doxorubicin-Induced Cytotoxicity to MCF-7 Human Breast Cancer Cells
Biol Pharm Bull
2015
38(5):703-9
PubMed ID: 25947916
DOI: 10.1248/bpb.b14-00780
|
|
5833
Sato M, Muguruma N, Nakagawa T, Okamoto K, Kimura T, Kitamura S, Yano H, Sannomiya K, Goji T, Miyamoto H, Okahisa T, Mikasa H, Wada S, Iwata M, Takayama T.
High antitumor activity of pladienolide B and its derivative in gastric cancer.
Cancer Sci
2014
105(1):110-6
PubMed ID: 24635824
DOI: 10.1111/cas.12317
|
|
15803
M. Sheikh Mohamed, Srivani Veeranarayanan, Hiroaki Minegishi, Yasushi Sakamoto, Yasuhiro Shimane, Yutaka Nagaoka, Atsushi Aki, Aby Cheruvathoor Poulose, Akinobu Echigo, Yasuhiko Yoshida, Toru Maekawa, D. Sakthi Kumar
Cytological and Subcellular Response of Cells Exposed to the Type-1 RIP Curcin and its Hemocompatibility Analysis
Scientific Reports
2014
4
DOI: 10.1038/srep05747
|
|
17110
Masanari Umemura, Ayako Makino, Itaru Sato, Xianfeng Feng, Kayoko Oda, Makoto Ohtake, Satoshi Izuka, Maki Iwai, Kosuke Matsuo, Haruki Eguchi, Yoshihiro Ishikawa
Abstract 5399: A novel treatment for triple-negative breast cancer using intrinsic magnetized paclitaxel
Cancer Research
2014
74:5399-5399
DOI: 10.1158/1538-7445.am2014-5399
|
|
14401
Yamaguchi Y, Deng D, Sato Y, Hou YT, Watanabe R, Sasaki K, Kawabe M, Hirano E, Morinaga T.
Silicate fiber-based 3D cell culture system for anticancer drug screening
Anticancer Res
2013
33(12):5301-9
PubMed ID: 24324063
|
|
17165
Nakagawa S, Matsuoka Y, Ichihara H, Yoshida H, Yoshida K, Ueoka R.
Therapeutic effects of autologous lymphocytes activated with trastuzumab for xenograft mouse models of human breast cancer
Biol Pharm Bull
2013
36(5):861-5
PubMed ID: 23649343
DOI: 10.1248/bpb.b12-01084
|
|
7842
Takahashi Y, Iwai M, Kawai T, Arakawa A, Ito T, Sakurai-Yageta M, Ito A, Goto A, Saito M, Kasumi F, Murakami Y.
Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer.
Breast Cancer
2012
19:242-52
PubMed ID: 21526423
DOI: 10.1007/s12282-011-0272-7
|
|
19336
Ruike Y, Imanaka Y, Sato F, Shimizu K, Tsujimoto G.
Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing
BMC Genomics
2010
11:137
PubMed ID: 20181289
DOI: 10.1186/1471-2164-11-137
|
|
8681
Shinya Shimoda, Hideaki Ichihara, Yoko Matsumoto, Ryuichi Ueoka
Nanoparticles of Hybrid Liposomes for the Inhibition of Breast Tumor Growth along with Apoptosis
Chemistry Letters
2009
38:134-135
DOI: 10.1246/cl.2009.134
|
|
18455
Shimoda S, Ichihara H, Matsumoto Y, Ueoka R.
Chemotherapy with hybrid liposomes for human breast tumors along with apoptosis in vivo
Int J Pharm
2009
372(1-2):162-8
PubMed ID: 19429276
DOI: 10.1016/j.ijpharm.2009.01.011
|
|
18469
Tsuna M, Kageyama S, Fukuoka J, Kitano H, Doki Y, Tezuka H, Yasuda H.
Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma
Anticancer Res
2009
29(7):2547-54
PubMed ID: 19596927
|
|
5877
Yamamoto H, Okumura K, Toshima S, Mukaisho K, Sugihara H, Hattori T, Kato M, Asano S.
FXYD3 protein involved in tumor cell proliferation is overproduced in human breast cancer tissues.
Biol Pharm Bull
2009
32(7):1148-54
PubMed ID: 19571376
DOI: 10.1248/bpb.32.1148
|
|
12771
Azumi K, Ikeda Y, Takeuchi T, Nomura T, Sabau SV, Hamada J, Okada F, Hosokawa M, Yokosawa H.
Localization and characterization of γ-glutamyl cyclotransferase in cancer cells
Mol Med Rep
2009
2(3):385-91
PubMed ID: 21475839
DOI: 10.3892/mmr_00000110
|
|
18925
Hata Y, Etoh T, Inomata M, Shiraishi N, Nishizono A, Kitano S.
Efficacy of oncolytic reovirus against human breast cancer cells
Oncol Rep
2008
19(6):1395-8
PubMed ID: 18497942
|
|
5012
Kawakami T, Chano T, Minami K, Okabe H, Okada Y, Okamoto K.
Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma.
Hum Mol Genet
2006
15(6):821-30
PubMed ID: 16439445
DOI: 10.1093/hmg/ddl001
|
|
2763
Ghosh, Mila, Koike, Naoto, Tsunoda, Shin-Ichi, Hirano, Takashi, Kaul, Sunil, Kashiwagi, Hironobu, Kawamoto, Toru, Ohkohchi, Nobuhiro, Saijo, Kaoru, Ohno, Tadao, Miwa, Masanao, Todoroki, Takeshi
Characterization and genetic analysis in the newly established human bile duct cancer cell lines.
Int J Oncol
2005
26:449-56
PubMed ID: 15645130
|
|
3023
Nishikawa, Kazuhiro, Satoh, Haruna, Hirai, Ayako, Suzuzki, Kazuyuki, Asano, Ryuji, Kumadaki, Itsumaro, Hagiwara, Kiyokazu, Yano, Tomohiro
alpha-Tocopheryloxybutyric acid enhances necrotic cell death in breast cancer cells treated with chemotherapy agent.
Cancer Lett
2003
201:51-6
PubMed ID: 14580686
DOI: 10.1016/s0304-3835(03)00462-2
|
|
3040
Satoh H, Nishikawa K, Suzuki K, Asano R, Virgona N, Ichikawa T, Hagiwara K, Yano T.
Genistein, a soy isoflavone, enhances necrotic-like cell death in a breast cancer cell treated with a chemotherapeutic agent.
Res. Commun. Mol. Pathol. Pharmacol.
2003
113-114:149-58
PubMed ID: 15686114
|
|
3019
Akazawa, Akihiko, Nishikawa, Kazuhiro, Suzuki, Kazuyuki, Asano, Ryuji, Kumadaki, Itsumaru, Satoh, Haruna, Hagiwara, Kiyokazu, Shin, Sung Jae, Yano, Tomohiro
Induction of apoptosis in a human breast cancer cell overexpressing ErbB-2 receptor by alpha-tocopheryloxybutyric acid.
Jpn J Pharmacol
2002
89:417-21
PubMed ID: 12233821
DOI: 10.1254/jjp.89.417
|
|
6400
Hatano H, Kawashima H, Ogose A, Hotta T, Endo N.
A PCR-ELISA assay for the detection of disseminated osteosarcoma cells in a mouse metastatic model.
J Orthop Sci
2001
6(3):269-75
PubMed ID: 11484122
DOI: 10.1007/s007760100046
|
Back
Top
CELL BANK Website
